扫描下面的二维码:
"热点聚焦"标签列表
[EASL重磅]3D方案治疗HIV/HCV难治人群数据荟萃及最新进展2016-05-05
[EASL重磅]DAA治疗HCV合并肝硬化患者可获高SVR和肝纤维化逆转2016-05-05
[EASL热点透视]唐红教授点评:DAA时代,肝移植后HCV感染复发患者是否需加用联合利巴韦林治疗?2016-04-17
[PHC视点]慢性HCV感染的优化治疗:疗程可以安全缩短吗?2016-03-11
[PHC视点]病例分享:慢性乙型肝炎的一线治疗2016-03-10
[PHC视点]哪些HCV感染患者应该接受治疗?2016-03-09
[病例分享]先天性非溶血性高胆红素血症1例2016-03-07
肝癌诊疗新工具ARCHTECT PIVKA-II2016-03-03
New Endpoints in HBV Drug Development2016-03-02
Portal Vein Thrombosis in Cirrhotic and Non-cirrhotic Liver2016-03-02
New Drugs to Overwhelm the Barriers to Eliminate HCV2016-03-02
Welcome Message——Jinlin Hou2016-03-02
LDV/SOF Efficacious in HCV Patients with Decompensated Cirrhosis2016-03-02
VEL/SOF Effective in HCV Patients with Decompensated Cirrhosis2016-03-02
REP2139-Ca, a Promising NAP to Treat HBV2016-03-02
At 38 years, just Young and Robust—25th APASL Opening Ceremony2016-03-02
For HBV/HCV Co-infection Patients in DAA Era, Treat the Viruses both!2016-03-02
Hepatitis B Treatment: Yesterday, Today and Tomorrow2016-03-02